BIIB vs ELF · P/E 21, rev $9.89B vs P/E 60, rev $332.6M
Biogen Inc (BIIB) versus ELF Beauty Inc (ELF) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ.
ELF Beauty Inc (ELF) is a household & personal products company listed on US.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported ELF revenue for 2025-03-31 was $332.6M. Net income was $28.3M. Revenue was down 6.4% from 2024-12-31 to 2025-03-31. ELF currently screens at market cap $6.55B and trailing P/E 60.1.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. ELF currently screens at market cap $6.55B and trailing P/E 60.1.
Not investment advice. Open the BIIB and ELF stock pages for the full models.
Not investment advice.